Cargando…

Dramatic Improvement of Pulmonary Tumor Thrombotic Microangiopathy in a Breast Cancer Patient Treated With Bevacizumab

A 47-year-old woman diagnosed with stage IV left-sided breast cancer (T3N3aM1; OSS, HEP, LYM) 6 months back presented with respiratory distress. On admission, she developed respiratory failure, requiring 4 L of oxygen support. Pulmonary embolism was ruled out because computed tomography revealed no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimura, Aki, Yamada, Akimitsu, Oshi, Masanori, Nakayama, Mina, Komura, Naohiro, Sugano, Teruyasu, Yamamoto, Shinya, Narui, Kazutaka, Endo, Itaru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681781/ https://www.ncbi.nlm.nih.gov/pubmed/38022402 http://dx.doi.org/10.14740/wjon1691

Ejemplares similares

Granulomatous mastitis in a male breast: A case report and review of literature
por: Kawashima, Kei, et al.
Publicado: (2023)

GALNT1 Expression Is Associated with Angiogenesis and Is a Prognostic Biomarker for Breast Cancer in Adolescents and Young Adults (AYA)
por: Oshi, Masanori, et al.
Publicado: (2023)

Development of a novel BRCAness score that predicts response to PARP inhibitors
por: Oshi, Masanori, et al.
Publicado: (2022)

Progressive bevacizumab-associated renal thrombotic microangiopathy*
por: Uy, Alice L., et al.
Publicado: (2009)

Imatinib dramatically alleviates pulmonary tumour thrombotic microangiopathy induced by gastric cancer
por: Kubota, Kana, et al.
Publicado: (2017)

A Case of BRCA2-Pathogenic Variant Breast Cancer With Metachronous Endometrial Cancer and Pancreatic Cancer
por: Oshi, Masanori, et al.
Publicado: (2023)

BRCA2 reversion mutation confers resistance to olaparib in breast cancer
por: Yamamoto, Shinya, et al.
Publicado: (2023)

Bevacizumab-Associated Thrombotic Microangiopathy Treated with Eculizumab: A Case Report
por: Padilha, Wallace Stwart Carvalho, et al.
Publicado: (2023)

Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report
por: Yamada, Ryo, et al.
Publicado: (2019)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

Primary breast lymphoma initially diagnosed as invasive ductal carcinoma: A case report
por: Uenaka, Natsuki, et al.
Publicado: (2021)

Overlap of Thrombotic Microangiopathy and Mesangial Proliferative Glomerulonephritis Caused by Combination Therapy with Atezolizumab and Bevacizumab
por: Horino, Taro, et al.
Publicado: (2022)

Pulmonary thrombotic microangiopathy caused by gastric carcinoma
por: Yokomine, Tatsuo, et al.
Publicado: (2010)

Thrombotic microangiopathy in children
por: Palma, Lilian Monteiro P., et al.
Publicado: (2022)

A case of matrix-producing carcinoma of the breast treated with preoperative chemotherapy
por: Kimura, Aki, et al.
Publicado: (2022)

Clinicopathological Characteristics and Prognosis of Triple-Negative Apocrine Carcinoma: A Case-Control Study
por: Suzuki, Chiho, et al.
Publicado: (2023)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
por: Grall, Maximilien, et al.
Publicado: (2021)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Thrombotic microangiopathy in renal allografts
por: Radha, S., et al.
Publicado: (2014)

Influenza-associated thrombotic microangiopathies
por: Bitzan, Martin, et al.
Publicado: (2017)

Acyclovir-induced thrombotic microangiopathy
por: Goli, R., et al.
Publicado: (2017)

Cancer-associated thrombotic microangiopathy
por: Govind Babu, K, et al.
Publicado: (2016)

Complement in Secondary Thrombotic Microangiopathy
por: Palma, Lilian Monteiro Pereira, et al.
Publicado: (2020)

Thrombotic Microangiopathy Syndrome in the ICU
por: Samy Modeliar, S., et al.
Publicado: (2006)

Thrombotic Microangiopathy Syndrome in the ICU
por: Samy Modeliar, S., et al.
Publicado: (2006)

COVID-19 and thrombotic microangiopathies
por: Tiwari, Nishant R., et al.
Publicado: (2021)

Thrombotic microangiopathy triggered by podocytopathy
por: Veríssimo, Rita, et al.
Publicado: (2021)

Thrombotic microangiopathies: An illustrated review
por: Abou‐Ismail, Mouhamed Yazan, et al.
Publicado: (2022)

Diagnosis and treatment of thrombotic microangiopathy
por: Thompson, Gemma L., et al.
Publicado: (2022)

Chemotherapy-Associated Thrombotic Microangiopathy
por: Aklilu, Abinet M., et al.
Publicado: (2023)

Renal-Limited Thrombotic Microangiopathy due to Bevacizumab Therapy for Metastatic Colorectal Cancer: A Case Report
por: Toriu, Naoya, et al.
Publicado: (2019)

Renal Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation: Involvement of Chronic Graft-Versus-Host Disease
por: Mii, Akiko, et al.
Publicado: (2018)

Breast carcinoma with spontaneous regression after needle biopsy: a case report and literature review
por: Sasamoto, Mahato, et al.
Publicado: (2023)

Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy
por: Wada, Hideo, et al.
Publicado: (2018)

Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports
por: Hsu, Ping-Chih, et al.
Publicado: (2023)

Thrombotic microangiopathy and associated renal disorders*
por: Barbour, Thomas, et al.
Publicado: (2012)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Thrombotic microangiopathy associated with proteasome inhibitors
por: Lodhi, Ahad, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_587jpmagqab0k68okg5kgaftgh